

SEATTLE, April 29 (UPI) -- A medication used to prevent fractures in women with osteoporosis, may be linked to a heightened risk of abnormal heart rhythm, a U.S. study said.
The medication, alendronate, may be associated with an increased risk of atrial fibrillation, says a study published in the Archives of Internal Medicine.
Dr. Susan R. Heckbert of the University of Washington and Group Health in Seattle and colleagues studied 719 women with confirmed atrial fibrillation that began between 2001 and 2004 and 966 control women of same age with no atrial fibrillation.
After adjusting for other risk factors, those taking alendronate were linked to a higher risk of atrial fibrillation compared with those who had never taken any bisphosphonate -- a class of drugs that help prevent osteoporosis.
The researchers estimate that about 3 percent of new atrial fibrillation cases in this population may be attributed to alendronate use, the study said.
|
|
|
|
|
|
| Additional Health News Stories | |
WASHINGTON, Feb. 10 (UPI) --
A woman who says she had an affair with President John F. Kennedy wrote that she didn't feel at the time she was "invading the Kennedys' marriage."
|
LOS ANGELES, Feb. 10 (UPI) --
Pop icon Madonna says she "wasn't happy" after rapper M.I.A. flipped her middle finger at a camera during the Super Bowl halftime show in Indianapolis.
|
BIRMINGHAM, England, Feb. 10 (UPI) --
A British company said it is opening salons across England dedicated to the tattooing the scalps of bald men to make it look like they have short hair.
|
WASHINGTON, Feb. 10 (UPI) --
The Nuclear Regulatory Commission approved the construction of two new nuclear reactors, the first to be built in the United States since 1978.
|
| Stories | Photos | People | Comments |
View Caption